Julie AllicksonDirector, Regenerative Medicine Clinical Center at Wake Forest Institute for Regenerative Medicine, USA
Julie Allickson, PhD , Director, Regenerative Medicine Clinical Center, Wake Forest Institute for Regenerative Medicine
Dr. Allickson has 30 years of experience in clinical translation of cellular therapies and regenerative medicine products including regulatory, business management and board directorship experience. She has 8 years’ experience as an executive officer with a publicly traded company building services for cellular banking including licensure of technology. Dr. Allickson is Director of the Regenerative Medicine Clinical Center at Wake Forest Institute for Regenerative Medicine. She heads the clinical translation team streamlining development to create a robust pipeline of products in development and early phase clinical trials including cell therapy, gene therapy, tissue engineered organs and tissues, biomaterials and devices. Prior to the Institute she was the Vice President of Research and Development and Laboratory Operations for Cryo-Cell International Inc. Dr. Allickson is on the Board of Directors for AABB and the Regenerative Medicine Outcomes Foundation as a scientific advisor, Editorial board of CELLR4, Vice Chair for Cord Blood Association Quality Committee, Technical Advisory Board for Tissue Engineered Products under ICCBBA, grant reviewer for state funded initiatives such as CIRM and serves on the ISCT Commercialization Committee.